Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Irhythm Technologies Inc (IRTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,686,059
  • Shares Outstanding, K 24,464
  • Annual Sales, $ 147,290 K
  • Annual Income, $ -48,280 K
  • 60-Month Beta 1.72
  • Price/Sales 11.36
  • Price/Cash Flow N/A
  • Price/Book 30.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.50
  • Number of Estimates 4
  • High Estimate -0.44
  • Low Estimate -0.53
  • Prior Year -0.47
  • Growth Rate Est. (year over year) -6.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.49 +5.24%
on 04/02/19
94.50 -27.07%
on 03/20/19
-22.34 (-24.48%)
since 03/18/19
3-Month
65.49 +5.24%
on 04/02/19
98.13 -29.77%
on 02/27/19
-13.86 (-16.74%)
since 01/18/19
52-Week
55.18 +24.90%
on 05/01/18
98.37 -29.94%
on 09/13/18
+5.72 (+9.05%)
since 04/18/18

Most Recent Stories

More News
Report: Exploring Fundamental Drivers Behind TG Therapeutics, IRHYTHM TECH, Sierra Metals, Zomedica Pharmaceuticals, Blonder Tongue Laboratories, and Newtek Business Services -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of TG Therapeutics, Inc. (NASDAQ:TGTX),...

TGTX : 7.83 (-3.81%)
NEWT : 20.77 (-0.19%)
BDR : 0.94 (+0.86%)
ZOM : 0.34 (+9.11%)
IRTC : 68.92 (+0.75%)
ZOMHF : 2.3445 (-0.40%)
SMTS : 1.53 (+0.50%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors (IRTC)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) investors concerning the Company and its...

IRTC : 68.92 (+0.75%)
Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties...

IRTC : 68.92 (+0.75%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors

Law Offices of Howard G. Smithannounces an investigation on behalf of iRhythm Technologies, Inc. investors ("iRhythm" or the "Company") (NASDAQ:IRTC) concerning the Company and its...

IRTC : 68.92 (+0.75%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors (IRTC)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) investors concerning the Company and its...

IRTC : 68.92 (+0.75%)
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or "the...

IRTC : 68.92 (+0.75%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors

Law Offices of Howard G. Smithannounces an investigation on behalf of iRhythm Technologies, Inc. investors ("iRhythm" or the "Company") (NASDAQ:IRTC) concerning the Company and its...

IRTC : 68.92 (+0.75%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or "the...

IRTC : 68.92 (+0.75%)
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.

Amyris, Inc. (AMRS)

QTNA : 24.28 (+0.25%)
AMRS : 5.02 (+20.10%)
WBC : 133.00 (+0.05%)
IRTC : 68.92 (+0.75%)
ORN : 2.71 (unch)
ZFGN : 2.59 (-3.00%)
OSMT : 4.08 (+1.24%)
Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. (IRTC) on Behalf of Stockholders and Encourages IRTC Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC). Our investigation concerns whether iRhythm has violated the federal securities laws and/or...

IRTC : 68.92 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More Share

Trade IRTC with:

Business Summary

iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics...

See More

Key Turning Points

2nd Resistance Point 70.99
1st Resistance Point 69.95
Last Price 68.92
1st Support Level 67.24
2nd Support Level 65.57

See More

52-Week High 98.37
Fibonacci 61.8% 81.87
Fibonacci 50% 76.78
Fibonacci 38.2% 71.68
Last Price 68.92
52-Week Low 55.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar